Research Opportunity:
Dr. Leonardi and his team at McMaster University in Hamilton, Canada are conducting an international survey study on the effect of Glucagon-Like Peptide (GLP)-1 medications on the management of endometriosis-related symptoms.
You can participate in this study if:
- you were assigned female at birth
- you are 18-55 years of age
- you have been diagnosed with, or are suspected to have, endometriosis
- you are currently taking or have taken Glucagon-Like Peptide-1 (GLP-1) medications in the past.
If you are unsure about taking GLP-1 medications, please refer to this comprehensive list: https://bit.ly/3NsFkPs.